Skip to main content
. 2022 Jan 15;14(1):55–74. doi: 10.4251/wjgo.v14.i1.55

Table 4.

Association with Helicobacter pylori infection and Esophageal cancer


Prevalence of H. pylori
Diagnostic tool of H. pylori
Study design
P value
Rokkas et al[44] EAC: 0.52 (95%CI: 0.37-0.73) Serology and/or histology Meta-analysis EAC: P < 0.001
ESCC: 0.85 (95%CI: 0.55-1.33) ESCC: P = 0.48
Islami et al[45] EAC: 0.56 (95%CI: 0.46-0.68) Serology and/or histology Meta-analysis NA
ESCC: 1.10 (95%CI: 0.78-1.55)
Nie et al[46] EAC: 0.57 (95%CI: 0.44-0.73) Serology and/or histology; rapid urease test Meta-analysis NA
ESCC:1.16 (95%CI: 0.8.-1.60)
Xie et al[47] EAC: 0.59 (95%CI: 0.51-0.68) Serology and/or histology; rapid urease test Meta-analysis NA
ESCC: 0.97 (95%CI: 0.76-1.24)
ESCC in Eastern: 0.66 (95%CI: 0.43-0.89)

CI: Confidence interval; H. pylori: Helicobacter pylori; EAC: Esophageal adenocarcinoma; ESCC: Esophageal squamous-cell carcinoma; NA: Not available.